Generics Firms Don’t Infringe Patents Just By Applying For Reimbursement, Australian Court Confirms
Executive Summary
Generics companies in Australia that seek a reimbursement listing for versions of originator drugs still under patent will not be infringing the patent provided that they do not offer to supply the products while the patent is still in force, a court has ruled.